233 related articles for article (PubMed ID: 9413764)
21. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia.
Maygarden SJ; Strom S; Ware JL
Arch Pathol Lab Med; 1992 Mar; 116(3):269-73. PubMed ID: 1371380
[TBL] [Abstract][Full Text] [Related]
22. Evidence of a novel biomarker, alphas1-Casein, a milk protein, in benign prostate hyperplasia.
Xu K; Ling MT; Wang X; Wong YC
Prostate Cancer Prostatic Dis; 2006; 9(3):293-7. PubMed ID: 16683014
[TBL] [Abstract][Full Text] [Related]
23. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
24. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. II. Rectal palpation, PSA, and transrectal echography].
Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Gómez dos Santos V; García González R
Arch Esp Urol; 1997 May; 50(4):339-45. PubMed ID: 9313042
[TBL] [Abstract][Full Text] [Related]
25. Ghrelin receptor as a novel imaging target for prostatic neoplasms.
Lu C; McFarland MS; Nesbitt RL; Williams AK; Chan S; Gomez-Lemus J; Autran-Gomez AM; Al-Zahrani A; Chin JL; Izawa JI; Luyt LG; Lewis JD
Prostate; 2012 Jun; 72(8):825-33. PubMed ID: 21919027
[TBL] [Abstract][Full Text] [Related]
26. Prostatic intraepithelial neoplasia: a lesion that may be confused with cancer on prostatic ultrasound.
Brawer MK; Rennels MA; Nagle RB; Soiderer MH; Lee F
J Urol; 1989 Dec; 142(6):1510-2. PubMed ID: 2479777
[TBL] [Abstract][Full Text] [Related]
27. Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia.
Bales GT; Flynn TJ; Kynaston HG; Golash A; Hart A; Kim HL; Gerber GS
Tech Urol; 2000 Sep; 6(3):201-4. PubMed ID: 10963487
[TBL] [Abstract][Full Text] [Related]
28. Estramustine-binding protein to dihydrotestosterone ratio in human prostatic carcinoma: a new marker for predicting disease progression.
Shiina H; Igawa M; Ishibe T
Br J Urol; 1996 Jan; 77(1):96-101. PubMed ID: 8653325
[TBL] [Abstract][Full Text] [Related]
29. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
Browne TJ; Hirsch MS; Brodsky G; Welch WR; Loda MF; Rubin MA
Hum Pathol; 2004 Dec; 35(12):1462-8. PubMed ID: 15619204
[TBL] [Abstract][Full Text] [Related]
30. Monodispersal and deoxyribonucleic acid analysis of prostatic cell nuclei.
Goerttler K; Ehemann V; Tschahargane C; Stoehr M
J Histochem Cytochem; 1977 Jul; 25(7):560-4. PubMed ID: 70447
[TBL] [Abstract][Full Text] [Related]
31. Minimum prostate-specific antigen (PSA) level diagnostic of prostate cancer.
Yesner R; Kelly LJ; Chan YK
Conn Med; 1996 Jul; 60(7):399-404. PubMed ID: 8758658
[TBL] [Abstract][Full Text] [Related]
32. Metachromasia in the human prostate: a histochemical difference between benign prostatic hyperplasia and prostatic carcinoma.
Arcadi JA
J Urol; 1988 Feb; 139(2):315-7. PubMed ID: 2448498
[TBL] [Abstract][Full Text] [Related]
33. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
[TBL] [Abstract][Full Text] [Related]
34. Cancer of the prostate: early diagnosis by zinc and hormone analysis?
Habib FK; Mason MK; Smith PH; Stitch SR
Br J Cancer; 1979 Jun; 39(6):700-4. PubMed ID: 87214
[TBL] [Abstract][Full Text] [Related]
35. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
Zeng L; Rowland RG; Lele SM; Kyprianou N
Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
[TBL] [Abstract][Full Text] [Related]
37. Expression of some selected cytokeratins and Ki67 protein in prostatic tumor: can these be used as tumor markers.
Adisa JO; Egbujo EC; Ibrahim B; Musa B; Madukwe J
Pan Afr Med J; 2015; 20():46. PubMed ID: 26090004
[TBL] [Abstract][Full Text] [Related]
38. Clinical assessment of the cancer diagnostic value of prostatic zinc: a comprehensive needle-biopsy study.
Cortesi M; Fridman E; Volkov A; Shilstein SSh; Chechik R; Breskin A; Vartsky D; Kleinman N; Kogan G; Moriel E; Gladysh V; Huszar M; Ramon J; Raviv G
Prostate; 2008 Jun; 68(9):994-1006. PubMed ID: 18386292
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
[TBL] [Abstract][Full Text] [Related]
40. Expression of macrophage migration inhibitory factor in the human prostate.
Meyer-Siegler K; Fattor RA; Hudson PB
Diagn Mol Pathol; 1998 Feb; 7(1):44-50. PubMed ID: 9646034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]